Sign Up Today and Learn More About Allorion Therapeutics Stock
Invest in or calculate the value of your shares in Allorion Therapeutics or other pre-IPO companies through EquityZen's platform.
Allorion Therapeutics Stock (ALLT)
Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.
About Allorion Therapeutics Stock
Founded
2020
Headquarters
Natick, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Allorion Therapeutics Press Mentions
Stay in the know about the latest news on Allorion Therapeutics
Allorion Therapeutics on LinkedIn: Please join us in welcoming John Campbell to Allorion as the leader of… | 52 ...
linkedin • May 19, 2024
Allorion Therapeutics describes new AKR1C3-targeting compounds
bioworld • May 13, 2024
Allorion inks another licensing deal, this one with Avenzo
thepharmaletter • May 03, 2024
Allorion Therapeutics identifies new CDK4/cyclin D1 inhibitors for cancer
bioworld • Feb 24, 2024
Allorion Therapeutics’ Licensing Agreement with Avenzo Therapeutics
globallegalchronicle • Feb 20, 2024
Allorion Therapeutics Management
Leadership team at Allorion Therapeutics
Founder and CEO
Qiang Ding
Board member
William Hu
Join now and verify your accreditation status to gain access to:
- Allorion Therapeutics current valuation
- Allorion Therapeutics stock price
- Available deals in Allorion Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Allorion Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Allorion Therapeutics through EquityZen funds. These investments are made available by existing Allorion Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Allorion Therapeutics stock?
Shareholders can sell their Allorion Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
